Related Experiment Video
Updated: Nov 24, 2025

08:13
Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
Published on: January 20, 2019
6.8K
Symptom cluster profiles following traumatic orthopedic injuries: A protocol
Stephen Breazeale1, Susan G Dorsey2, Joan Kearney1
1Yale School of Nursing, West Haven, Connecticut, USA.
Research in Nursing & Health
|December 28, 2020
Summary
Identifying symptom clusters after traumatic orthopedic injuries (TOI) is crucial. This study investigates how brain-derived neurotrophic factor (BDNF) relates to these symptom profiles in TOI survivors.
Area of Science:
- Trauma and Orthopedic Surgery
- Neuroscience
- Psychiatry
Background:
- Traumatic orthopedic injuries (TOI) affect millions, incurring significant costs and leading to prevalent post-injury symptoms.
- Symptoms like pain, sleep disturbance, anxiety, and depression often co-occur in clusters, impacting overall health.
- Understanding these symptom clusters is vital for identifying individuals at risk for negative long-term outcomes.
Purpose of the Study:
- To present the protocol for a cross-sectional study on symptom cluster profiles in TOI survivors.
- To identify symptom cluster profiles immediately following TOI.
- To examine the association of brain-derived neurotrophic factor (BDNF) levels and its val66met mutation with symptom cluster membership.
Main Methods:
- Recruitment of 150 TOI survivors within 72 hours of injury.
- Assessment of symptom clusters including pain, sleep disturbance, anxiety, depression, and stressor-related disorders.
- Measurement of serum BDNF concentrations and genotyping for the BDNF val66met mutation.
Main Results:
- The study aims to describe symptom cluster profiles in TOI survivors.
- It will examine demographic and clinical factors associated with symptom cluster membership.
- Hypotheses will test the association of low serum BDNF and the BDNF val66met mutation with symptom cluster profiles.
Conclusions:
- Identifying symptom cluster profiles following TOI is a key step towards understanding patient heterogeneity.
- BDNF dysregulation may represent a biological mechanism underlying these symptom clusters.
- Findings could inform future precision-health strategies for managing post-TOI symptoms.

